After being recognized with stage 3 triple-negative breast most cancers the day after her twenty ninth birthday, Meagan Pettit underwent chemotherapy, a...
The U.S. Meals and Drug Administration (FDA) has accepted for precedence evaluate a supplemental biologics license software (sBLA) for Padcev (enfortumab vedotin-ejfv)...
